These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34046568)

  • 1. Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Hassan W; Behiry E; Mahgoub M
    Arch Rheumatol; 2021 Mar; 36(1):47-55. PubMed ID: 34046568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.
    Mosaad NA; Lotfy HM; Farag YM; Mahfouz RH; Shahin RM
    Immunol Lett; 2017 Jan; 181():16-19. PubMed ID: 27838471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
    Liphaus BL; Silva SC; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Front Immunol; 2024; 15():1327255. PubMed ID: 38562920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients.
    Fawzy R; Serag M; Soliman A; Elwia S; Mojahed S
    Arch Rheumatol; 2022 Dec; 37(4):527-535. PubMed ID: 36879566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study.
    Gamal SM; Fouad N; Yosry N; Badr W; Sobhy N
    Arch Rheumatol; 2022 Jun; 37(2):280-287. PubMed ID: 36017206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
    Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis.
    Baraka E; Hashaad N; Abdelhalim W; Elolemy G
    Arch Rheumatol; 2023 Mar; 38(1):56-66. PubMed ID: 37235126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus - a prospective cohort study.
    Zhang RJ; Zhang X; Chen J; Shao M; Yang Y; Balaubramaniam B; Sun XL; Ambrus JL; He J; Li ZG
    Lupus; 2018 Jun; 27(7):1100-1106. PubMed ID: 29482443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus.
    Watson L; Midgley A; Pilkington C; Tullus K; Marks S; Holt R; Jones C; Beresford M
    Lupus; 2012 Apr; 21(5):496-501. PubMed ID: 22147846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
    Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
    Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
    Patel M; Oni L; Midgley A; Smith E; Tullus K; Marks SD; Jones CA; Pilkington C; Beresford MW
    Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
    Smith EMD; Jorgensen AL; Beresford MW;
    Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
    Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
    Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study.
    Smith EMD; Yin P; Jorgensen AL; Beresford MW
    Lupus; 2018 Nov; 27(13):2020-2028. PubMed ID: 30246602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.